The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Monday's prices. Each symbol is a hyperlink or shortcut to more information.

GILD 1.97%

Profile NASDAQ: GILD $82 Billion Large-Cap. Show More

GILD Profile

Market Cap 82 Billion
GILD Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Visit Website

GILD Earnings

EPS -0.92 P/E Ratio --
Previous Tue, Jul 30, 2019
Latest Thu, Oct 24, 2019 (25 days ago) Price -2.27%

GILD Dividend

Yield 3.50% / $2.28
Ex-Date Thu, Dec 13, 2018 (340 days ago)
Pay Date Fri, Dec 28, 2018

GILD Charts

52 Week Low $60.32 on Wed, Dec 26, 2018.
1 Year
Dec 26, 2018
Dec 3, 2018

Symbol Price Day Ξ” YTD Ξ”
GILD $65.07 1.97% 2.57%


Symbol Surfing

How can we make Symbol Surfing better?


©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy